Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Costa Rica
May 1, 2014, 00:00
10.1016/j.jval.2014.03.497
https://www.valueinhealthjournal.com/article/S1098-3015(14)00548-8/fulltext
Title :
Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Costa Rica
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00548-8&doi=10.1016/j.jval.2014.03.497
First page :
A85
Section Title :
Cancer
Open access? :
No
Section Order :
1547